Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

In Vitro Drug Dissolution: Compendial Testing Models I

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...

In Vitro Drug Dissolution: Compendial Testing Models II

In Vitro Drug Dissolution: Compendial Testing Models II

Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...

In Vitro Drug Dissolution: Alternative Methods

In Vitro Drug Dissolution: Alternative Methods

Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...

Drug Dissolution: Requirements and Profile Comparison

The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...

Clinically Relevant Drug Product Specifications: Methods of Establishment

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...

In Vitro Drug Release Testing: Overview, Development and Validation

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

From barriers to cloud-based regulatory collaboration: An industry perspective on accelerating innovation in pharmaceutical manufacturing.

Journal of pharmaceutical sciences·2026

Same author

Pioneering the future: Delivering the first digitally generated CMC post-approval change dossier to global regulators simultaneously.

Journal of pharmaceutical sciences·2026

Same author

Computational analysis reveals non-consensus N-glycosylation sequons in antibody Fab region.

mAbs·2025

Same author

A Novel C-terminal Sequence Variant Discovered in an IgG1 Monoclonal Antibody by LC-MS.

Journal of the American Society for Mass Spectrometry·2025

Same author

Discovery and Characterization of Novel G0 Glycan Isomers in an Afucosylated Therapeutic Antibody Using Liquid Chromatography-Mass Spectrometry.

Journal of the American Society for Mass Spectrometry·2025

Same author

Advancing the implementation of innovative analytical technologies in pharmaceutical manufacturing-Some regulatory considerations.

Journal of pharmaceutical sciences·2024

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

Coherent anti-Stokes Raman Scattering (CARS) Microscopy Visualizes Pharmaceutical Tablets During Dissolution

Coherent anti-Stokes Raman Scattering (CARS) Microscopy Visualizes Pharmaceutical Tablets During Dissolution

Published on: July 4, 2014

Development and application of a biorelevant dissolution method using USP apparatus 4 in early phase formulation

Jiang B Fang¹, Vivian K Robertson, Archana Rawat

¹Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA. fang@amgen.com

Molecular Pharmaceutics

|August 13, 2010

Summary

A new biorelevant dissolution method using USP apparatus 4 and biorelevant media improves early drug product development. This approach enhances formulation selection and predicts in vivo drug release, potentially reducing clinical studies.

More Related Videos

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

Published on: August 9, 2022

Related Experiment Videos

Last Updated: Jun 10, 2026

Coherent anti-Stokes Raman Scattering (CARS) Microscopy Visualizes Pharmaceutical Tablets During Dissolution

Coherent anti-Stokes Raman Scattering (CARS) Microscopy Visualizes Pharmaceutical Tablets During Dissolution

Published on: July 4, 2014

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

Published on: August 9, 2022

Area of Science:

Pharmaceutical Sciences
Drug Delivery
Biopharmaceutics

Background:

Traditional dissolution testing is crucial for drug product development but often lacks biorelevance.
Current methods primarily focus on quality control and achieving 100% drug release, limiting early-phase application.
Biorelevance is essential for predicting in vivo performance during formulation development.

Purpose of the Study:

To develop and demonstrate a biorelevant in vitro dissolution method for early-phase drug product development.
To showcase the application of this method in formulation selection, lot variability assessment, and food effect studies.
To establish a tool for predicting in vivo drug release and optimizing pharmacokinetic studies.

Main Methods:

Development of a biorelevant dissolution method utilizing USP Apparatus 4.
Employing biorelevant media to simulate physiological conditions.
Incorporating real-time online UV analysis for precise drug release monitoring.

Main Results:

The developed biorelevant dissolution method demonstrated utility in formulation selection.
The method effectively assessed lot-to-lot variability and food effects on drug release.
Case studies confirmed the method's ability to predict in vivo drug release characteristics.

Conclusions:

The biorelevant dissolution method using USP Apparatus 4 offers a valuable tool for early formulation development.
This approach facilitates informed formulation selection for pharmacokinetic and clinical studies.
The method has the potential to streamline drug development by minimizing the number of required pharmacokinetic studies.